Colinz Laboratories P/E Ratio

Current P/E Ratio
11.15
Low Valuation
Low - May indicate good value opportunity

Colinz Laboratories (COLINZ) P/E ratio is 11.15 (Low), EPS (TTM) ₹2.04, current price ₹42.01 on BSE — Low - May indicate good value opportunity. Analyse Colinz Laboratories ownership structure to track promoter, FII and institutional holdings.

Current Valuation Metrics

P/E Ratio 11.15
Current Price ₹42.01
EPS (TTM) ₹2.04
Exchange BSE

Valuation Signal

Signal Undervalued

Sector Context

Sector Average 50.08
Sector Median 29.4
Sector Rank #11 of 190
Sector Percentile 5.8%

COLINZ P/E Ratio — Valuation Signal & Historical Context

Colinz Laboratories P/E 11.15 — signal: Undervalued. For live price, revenue and the complete fundamental profile, see Colinz Laboratories share price today.

  • Stock appears undervalued with PE of 11.15, suggesting potential buying opportunity
  • Trading at discount to sector average PE of 50.08

COLINZ vs Healthcare Peers — P/E Ratio Comparison

Colinz Laboratories P/E 11.15 vs Healthcare average 50.08, median 29.4 — range 1.0–869.57.

Sector Average
50.08
Sector Median
29.4
Lowest P/E
1.0
Highest P/E
869.57
Companies
190
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.0 ₹36 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.45 ₹61 Low
Ind Swift Laboratories INDSWFTLAB 4.69 ₹1,161 Low
Amwill Health Care AMWILL 6.34 ₹65 Low
Brooks Laboratories BROOKS 6.6 ₹137 Low
Mono Pharmacare MONOPHARMA 7.1 ₹21 Low
Shelter Pharma SHELTER 7.4 ₹54 Low
Medicamen Organics MEDIORG 7.51 ₹32 Low
Zenith Drugs ZENITHDRUG 7.69 ₹66 Low